MTAP and central nervous system cancer: Despite the frequent loss of MTAP expression in high-grade gliomas, MTAP did not appear to be associated with a deteriorating outcome, and in-vitro models demonstrated that MTAP did not affect proliferation, invasion, and migration (32).